Cero Therapeutics Holdings Files Proxy Statement
Ticker: CEROW · Form: DEF 14A · Filed: May 7, 2025 · CIK: 1870404
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Cero Therapeutics proxy filed. Vote on directors May 29th.
AI Summary
Cero Therapeutics Holdings, Inc. filed its definitive proxy statement on May 7, 2025, for its annual meeting on May 29, 2025. The company, formerly known as Phoenix Biotech Acquisition Corp., is based in South San Francisco, CA, and operates in the biological products sector. This filing outlines the proposals to be voted on by shareholders, including the election of directors and other corporate governance matters.
Why It Matters
This filing provides shareholders with crucial information to make informed decisions regarding company leadership and corporate governance at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting and does not contain new financial or strategic information that would inherently increase risk.
Key Numbers
- 20250529 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
- 20250507 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
Key Players & Entities
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Registrant
- PHOENIX BIOTECH ACQUISITION CORP. (company) — Former company name
- 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA 94080 (company) — Business and mailing address
- 650-407-2376 (dollar_amount) — Business phone number
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the upcoming annual meeting, including proposals to be voted on, such as the election of directors.
When is the annual meeting scheduled to take place?
The annual meeting is scheduled for May 29, 2025.
What was Cero Therapeutics Holdings, Inc. formerly known as?
Cero Therapeutics Holdings, Inc. was formerly known as Phoenix Biotech Acquisition Corp.
Where is Cero Therapeutics Holdings, Inc. located?
The company's business and mailing address is 201 Haskins Way, Suite 230, South San Francisco, CA 94080.
What industry does Cero Therapeutics Holdings, Inc. operate in?
The company operates in the Biological Products (No Diagnostic Substances) industry, SIC code 2836.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 7, 2025 regarding CERO THERAPEUTICS HOLDINGS, INC. (CEROW).